Cargando…
Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
OBJECTIVE: Converging evidence suggests that intestinal inflammation is involved in the pathogenesis of neurodegenerative diseases. Previous studies on fecal calprotectin in Parkinson’s disease (PD) were limited by small sample sizes, and literature regarding intestinal inflammation in multiple syst...
Autores principales: | Hor, Jia Wei, Lim, Shen-Yang, Khor, Eng Soon, Chong, Kah Kian, Song, Sze Looi, Ibrahim, Norlinah Mohamed, Teh, Cindy Shuan Ju, Chong, Chun Wie, Hilmi, Ida Normiha, Tan, Ai Huey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171316/ https://www.ncbi.nlm.nih.gov/pubmed/34937162 http://dx.doi.org/10.14802/jmd.21085 |
Ejemplares similares
-
Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021) -
Probiotics for Parkinson's disease: Current evidence and future directions
por: Tan, Ai Huey, et al.
Publicado: (2020) -
Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016) -
The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019) -
Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)